Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 28, 2014; 20(48): 18199-18206
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18199
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18199
Table 6 Number of patients receiving concomitant medication
| Endoscopic balloon dilatation (n = 9) | Biodegradable stent (n = 6) | |
| Bowel management | ||
| Loperamide | 1 | 0 |
| Constipation | ||
| Laxative | 1 | 2 |
| Haematemesis | ||
| Metoclopramide | 0 | 1 |
| Heartburn | ||
| Alginate | 0 | 1 |
| Nausea/vomiting | 1 | 4 |
| Cyclizine | 0 | 3 |
| Domperidone | 0 | 2 |
| Metoclopramide | 1 | 4 |
| Nutritional deficit | ||
| Nutritional Supplement | 1 | 4 |
| Oesophageal candidiasis | ||
| Antifungal | 0 | 1 |
| Symptoms of BOS/reflux disease | 6 | 9 |
| Proton pump inhibitor | 5 | 9 |
| H2-receptor antagonist | 1 | 2 |
| Sucralfate | 0 | 1 |
- Citation: Dhar A, Close H, Viswanath YK, Rees CJ, Hancock HC, Dwarakanath AD, Maier RH, Wilson D, Mason JM. Biodegradable stent or balloon dilatation for benign oesophageal stricture: Pilot randomised controlled trial. World J Gastroenterol 2014; 20(48): 18199-18206
- URL: https://www.wjgnet.com/1007-9327/full/v20/i48/18199.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i48.18199